Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1995 2
1996 1
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3 results

Results by year

Citations

1 article found by citation matching

Search results

Filters applied: . Clear all
Page 1
Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS).
Hacke W, Kaste M, Fieschi C, Toni D, Lesaffre E, von Kummer R, Boysen G, Bluhmki E, Höxter G, Mahagne MH, et al. Hacke W, et al. JAMA. 1995 Oct 4;274(13):1017-25. JAMA. 1995. PMID: 7563451 Clinical Trial.
OBJECTIVE: To evaluate the efficacy and safety of intravenous thrombolysis using recombinant tissue plasminogen activator (rt-PA) in patients with acute ischemic stroke. ...SETTING: A total of 75 hospitals in 14 European
OBJECTIVE: To evaluate the efficacy and safety of intravenous thrombolysis using recombinant tissue plasminog
European Cooperative Acute Stroke Study (ECASS): (rt-PA-Thrombolysis in acute stroke) study design and progress report.
Boysen G; ECASS Study Group. Boysen G, et al. Eur J Neurol. 1995 Jan;1(3):213-9. doi: 10.1111/j.1468-1331.1995.tb00074.x. Eur J Neurol. 1995. PMID: 24283521
The purpose of the ECASS study is to evaluate whether thrombolytic therapy with recombinant tissue plasminogen activator, alteplase, improves outcome compared to a placebo-treated control group. Patients with acute ischemic hemi
The purpose of the ECASS study is to evaluate whether thrombolytic therapy with recombinant tissue plasminoge
Thrombolysis acute ischemic stroke.
Fieschi C, Cavalletti C, Toni D, Fiorelli M, Sacchetti ML, De Michele M, Gori MC, Montinaro E, Argentino C. Fieschi C, et al. Acta Neurochir Suppl. 1996;66:76-80. doi: 10.1007/978-3-7091-9465-2_14. Acta Neurochir Suppl. 1996. PMID: 8780802 Review.
The safety and efficacy of the treatment critically depend on the timing of intervention ad on patient selection. In recent studies on ischemic stroke, spontaneous hemorrhagic transformation of an infarct seems to be related to the size of the lesion, and can be rel …
The safety and efficacy of the treatment critically depend on the timing of intervention ad on patient selection. In recent studies o …